🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the use of ctDNA measurements t...
Status
Recruiting
Location
NYU Langone Health
Start Date
2026-04-13
Trial ID
NCT07504796
Treatments Being Tested
The goal of this clinical trial is to assess if circulating tumor DNA, as a...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09
Trial ID
NCT07565857
Treatments Being Tested
Primary Objective: 1\) To examine the impact of Circulating tumor DNA (ctD...
Status
Active Not Recruiting
Location
Trinitas Hospital and Comprehensive Cancer Center
Start Date
2022-04-06
Trial ID
NCT05333874
Treatments Being Tested
Thie purpose of this study is to find out whether a personalized treatment ...
Status
Recruiting
Location
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Start Date
2026-03-04
Trial ID
NCT07459673
This is a single-arm observational study to determine the feasibility of as...
Status
Withdrawn
Location
Froedtert & the Medical College of Wisconsin
Start Date
2021-03-31
Trial ID
NCT04670588
Treatments Being Tested
Anti-HER2 therapy, such as trastuzumab and pertuzumab, has significantly im...
Status
Active Not Recruiting
Location
Natera
Start Date
2024-04-01
Trial ID
NCT06663787
Treatments Being Tested
This study will look at the recurrence-free survival of microsatellite-stab...
Status
Withdrawn
Location
UF Health Davis Cancer Pavilion and Shands Med Plaza
Start Date
2022-06-24
Trial ID
NCT05178576
Treatments Being Tested
The BESPOKE CRC study will prospectively enroll patients who have undergone...
Status
Unknown
Location
San Carlos
Start Date
2020-04-24
Trial ID
NCT04264702
Heroes is a multicentre, national, non-randomized, open-label, phase 2 stud...
Status
Recruiting
Location
Centre Eugène marquis
Start Date
2025-01-25
Trial ID
NCT06450314
Treatments Being Tested
Adding immune checkpoint inhibitors or molecularly targeted drugs as adjuva...
Status
Not Yet Recruiting
Location
National Cancer Center Hospital
Start Date
2025-03-01
Trial ID
NCT06854939